Strategic Targeting of Cathepsin B: Advancing Necroptosis...

2025-10-21

This thought-leadership article unpacks the critical role of cathepsin B in regulated cell death, integrating recent mechanistic breakthroughs on MLKL-induced lysosomal membrane permeabilization (LMP) and necroptosis. It offers translational researchers actionable experimental and strategic guidance on utilizing CA-074 Me—a highly selective, cell-permeable cathepsin B inhibitor—to dissect and manipulate lysosomal signaling pathways. The discussion contextualizes CA-074 Me within the competitive landscape, highlights clinical relevance, and maps out future directions for disease modulation and translational research, while escalating the conversation beyond standard product literature.